Codeine cough-and-cold medicines in children: A never ending story – FDA evaluating potential risk of serious side effects

Last Updated on

July 6. 2015 – The American Food and Drug Administration (FDA) is once more investigating the safety of using codeine-containing medicines to treat coughs and colds in children under 18 years because of the potential for serious side effects, including slowed or difficult breathing. Children, especially those who already have breathing problems, may be more susceptible to these serious side effects. Already in 2013, FDA warned against using codeine in children who Codeine IIrecently had surgery to remove their tonsils and/or adenoids. In April 2015, the European Medicines Agency (EMA) announced that codeine must not be used to treat cough and cold in children under 12 years, and that codeine is not recommended in children and adolescents between 12 and 18 years who have breathing problems, including those with asthma and other chronic breathing problems. FDA will continue to evaluate this safety issue and will consider the EMA recommendations. Final conclusions and recommendations will be communicated when the FDA review is complete.

Background and Recommendations: : Codeine is a specific type of narcotic medicine called an opioid that is used to treat mild to moderate pain and also to reduce coughing.  It is usually combined with other medications in prescription and over-the-counter (OTC) cough-and-cold medicines. Parents and caregivers who notice any signs of slow or shallow breathing, difficult or noisy breathing, confusion, or unusual sleepiness in their child should stop giving their child codeine and seek medical attention immediately by taking their child to the emergency room or calling 911.  Parents and caregivers should always read the product label to find out if a medicine contains codeine and talk with their child’s health care professional or a pharmacist if they have any questions or concerns.  Health care professionals should continue to follow the recommendations in the drug labels and use caution when prescribing or recommending codeine-containing cough-and-cold medicines to children.

Here, one might add that individuals with high levels of CYP2D6 enzymatic activity (of the CYP2D6 ultrarapid metabolizer phenotype, or the CYP2D6 extensive metabolizer phenotype with enzymatic activity at the upper end of the spectrum of activities in this patient subgroup) might be at risk for hightened metabolic conversion of codeine to morphine, which in turn may have a negative effect on the breathing capability of an affected individual. In very rare and dramatic cases, morphine may lead to a fatal obstructive sleep apnea syndrome. As a parent of 4 kids, before using codeine-containg sirops, I would certainly like to know what the genotype status of my children at the CYP2D6 locus is, and whether they fall into the CYP2D6 slow metabolizer patient subgroup. the CYP2D6 extensive metabolizer patient subgroup, or the CYP2D6 ultrarapid metabolizer patient subgroup. If the latter were true, I would be very cautios, even with over the counter (OTC) type of medicines.

Tags: , , , , , , , , ,
About the Author
thassodotcom Ph.D.; Professor in Pharmacology and Toxicology. Senior expert in theragenomic and personalized medicine and individualized drug safety. Senior expert in pharmaco- and toxicogenetics. Senior expert in human safety of drugs, chemicals, environmental pollutants, and dietary ingredients.

Leave a Reply

Optional: Social Subscribe/Login




avatar
  Subscribe  
Notify of
trackback

[…] bekommen haben und dabei CYP2D6-Ultrarapid-Metaboliser-Phänotyp von Codein waren (siehe auch einen früheren Artikel von […]

trackback

[…] and were ultra-rapid metabolizers of codeine (see the FDA Safety Communication and an earlier article by thasso). Children of different ethnic background may have a very different risk for this […]

trackback

[…] Post veröffentlichte kürzlich zwei Artikel, welche auf auf diesen Umstand aufmerksam machen; ein Artikel bezog sich auf eine entsprechende FDA-FMitteilung und ein zweiter Artikel reflektierte eine […]

trackback

[…] to a much higher extend than normal. Thasso Post has recently published two articles to that fact; one article referred to an according FDA release and one article referred to a similar release by the European […]

thasso: conditions

thasso: tweets

thasso post: magazine

View my Flipboard Magazine.

thasso: categories

thasso: archives

thasso: simple chat

You must be a registered user to participate in this chat.

  • Scientists use gene-editing tool CRISPR in attempt to cure HIV September 13, 2019
    The first attempt to use the gene-editing tool CRISPR to cure HIV infection was unsuccessful but the approach does show promise.
  • New cardiac fibrosis study identifies key proteins that translate into heart disease September 12, 2019
    Using cutting-edge technologies, researchers at Duke-NUS Medical School, Singapore, have developed the first genome-wide dataset on protein translation during fibroblast activation, revealing a network of RNA-binding proteins (RBPs) that play a key role in the formation of disease-causing fibrous tissue in the heart. Their findings, published in the journal Circulation, could help in the search […]
  • How your genes affect the number on your scale September 12, 2019
    Could your genes be keeping you from losing weight?
  • Scientists identify gene as master regulator in schizophrenia September 11, 2019
    Using computational tools to investigate gene transcription networks in large collections of brain tissues, a scientific team has identified a gene that acts as a master regulator of schizophrenia during early human brain development. The findings may lay the groundwork for future treatments for the highly complex neuropsychiatric disorder.
  • How your DNA takes shape makes a big difference in your health September 11, 2019
    The more we learn about our genome, the more mysteries arise. For example, how can people with the same disease-causing mutation have different disease progression and symptoms? And despite the fact that it's been more than 15 years since the human genome was sequenced, why can't we explain the significance of the vast majority of […]
Top